The U.K.-based biotech, Myricx Bio, is the latest to cash in on the hot antibody-drug conjugate space, closing a $115.5 million Series A round co-led by Novo Holdings and with participation from Eli Lilly and Company. https://lnkd.in/gJ-VKekY #pharma #seriesA #biospace
BioSpace
Internet News
West Des Moines, Iowa 112,001 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Updates
-
GLP-1 receptor agonists could reduce the risk of 10 obesity-associated cancers, such as meningioma, multiple myeloma and colorectal cancer, in type 2 diabetes patients, according to an analysis of electronic health records. https://lnkd.in/gJX7k6W3 #pharma #biospace
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study | BioSpace
biospace.com
-
Roche's tiragolumab, when combined with its PD-L1 blocker Tecentriq, did not significantly improve progression-free and overall survival versus Keytruda and chemotherapy in patients with non-small cell lung cancer. https://lnkd.in/gazpKAFU #pharma #biospace
Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo | BioSpace
biospace.com
-
A federal judge ruled last week that the U.S. government can use its economic standing as a bulk drug purchaser to negotiate for better deals, handing Boehringer Ingelheim a loss in its legal challenge to the Inflation Reduction Act. https://lnkd.in/gRm7nyG8 #pharma #ira #biospace
Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling | BioSpace
biospace.com
-
Eli Lilly and Company, Rivus Pharmaceuticals and more target different biological processes in hopes of generating higher-quality weight loss and avoiding metabolic issues. https://lnkd.in/gSEpqQ4Y #pharma #biospace
Beyond GLP-1s: The Next Obesity Treatments | BioSpace
biospace.com
-
With the antibody drug conjugate market projected to hit $28 billion by 2028, some companies are looking to harness the drugs for immunotherapy. https://hubs.li/Q02FyS5B0
Drug Developers Tap the Immune System to Supercharge ADCs | BioSpace
biospace.com
-
Patient assistance programs may actually be a two-way street, providing patients with drugs and companies with data. https://hubs.li/Q02Fzfw_0
Patient Assistance Programs: A Source of Real-World Data? | BioSpace
biospace.com
-
Despite an uncertain legislative path to becoming law, the BIOSECURE Act has already impacted the biopharma industry’s confidence in Chinese service providers and prompted efforts to diversify manufacturing partners. https://hubs.li/Q02FfWYy0
BIOSECURE Act Erodes Industry Confidence in Chinese Contractors: Report | BioSpace
biospace.com
-
Biopharma Layoff Tracker 2024: Apollomics, CureVac, Takeda and More Cut Staff https://hubs.li/Q02FfXbg0
Biopharma Layoff Tracker 2024: Apollomics, CureVac, Takeda and More Cut Staff | BioSpace
biospace.com
-
Taysha Gene Therapies looks to move past its pipeline culls and staff reductions by moving its lead asset into a possible billion-dollar market. https://hubs.li/Q02Ff_nC0
Taysha Shares Positive Rett Results in Bid to Move Past Roadblocks | BioSpace
biospace.com